Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome : A novel marker for early diagnosis

• Published in: Circulation (New York, N.Y.) N.Y.), 2005-08, Vol.112 (6), p.812-818
• Main Authors: HAYASHIDA, Kazutaka, KUME, Noriaki, KIMURA, Takeshi, KITA, Toru, MURASE, Takatoshi, MINAMI, Manabu, NAKAGAWA, Daisuke, INADA, Tsukasa, TANAKA, Masaru, UEDA, Akira, KOMINAMI, Goro, KAMBARA, Hirofumi
• Format: Article
• Language: English
• Subjects: Acute Disease; Aged; Biological and medical sciences; Biomarkers - blood; Blood and lymphatic vessels; Blood. Blood coagulation. Reticuloendothelial system; Cardiology. Vascular system; Coronary Angiography; Coronary Artery Disease - blood; Coronary Disease - blood; Coronary Disease - diagnosis; Coronary heart disease; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous; Female; Heart; Humans; Lectins - blood; Male; Medical sciences; Middle Aged; Pharmacology. Drug treatments; Scavenger Receptors, Class E - blood
• ISSN: 0009-7322; 1524-4539
• DOI: 10.1161/CIRCULATIONAHA.104.468397

Markers of cardiac injury, including troponin-T (TnT), are used to diagnose acute coronary syndrome (ACS); however, markers for plaque instability may be more useful for diagnosing ACS at the earliest stage. Lectin-like oxidized LDL receptor-1 (LOX-1) appears to play crucial roles in the pathogenesis of atherosclerotic plaque rupture and ACS onset. LOX-1 is released in part as soluble LOX-1 (sLOX-1) by proteolytic cleavage. We examined serum sLOX-1 levels in 521 patients, consisting of 427 consecutive patients undergoing coronary angiography, including 80 ACS patients, 173 symptomatic coronary heart disease patients, 122 patients with significant coronary stenosis without ischemia, and 52 patients without apparent coronary atherosclerosis plus 34 patients with noncardiac acute illness and 60 patients with noncardiac chronic illness. Time-dependent changes in sLOX-1 and TnT levels were analyzed in an additional 40 ACS patients. Serum sLOX-1 levels were significantly higher in ACS than the other groups and were associated with ACS as shown by multivariable logistic regression analyses. Given a cutoff value of 1.0 ng/mL, sLOX-1 can discriminate ACS from other groups with 81% and 75% of sensitivity and specificity, respectively. sLOX-1 can also discriminate ACS without ST elevation or abnormal Q waves and ACS without TnT elevation from non-ACS with 91% and 83% of sensitivity, respectively. Peak values of sLOX-1 in ACS were observed earlier than those of TnT. sLOX-1 appears to be a useful marker for early diagnosis of ACS.